PMC:7055038 / 3236-4029 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"58","span":{"begin":156,"end":159},"obj":"Species"},{"id":"59","span":{"begin":668,"end":675},"obj":"Species"},{"id":"60","span":{"begin":713,"end":723},"obj":"Species"},{"id":"61","span":{"begin":316,"end":335},"obj":"Disease"}],"attributes":[{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"Tax:11118"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"Tax:9606"},{"id":"A60","pred":"tao:has_database_id","subj":"60","obj":"Tax:2697049"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D003141"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Clinical specimens collected on admission included the upper respiratory tract secretions and sputum. These specimens tested positive on 12 January for the CoV family by using a conventional nested RT-PCR [9]. Genomic sequencing analysis included Sanger and next generation sequencing were performed by the Emerging Infectious Diseases Health Science Center, the Thai Red Cross Society and the Thai National Institute of Health, Department of Medical Sciences and the sequence shared via the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database (EPI_ISL_403962). The sequencing protocol and details are provided in the Supplementary Materials. The patient recovered after testing negative for SARS-CoV-2, and returned to China without signs and symptoms on 18 January 2020."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T16","span":{"begin":55,"end":78},"obj":"Body_part"},{"id":"T17","span":{"begin":94,"end":100},"obj":"Body_part"}],"attributes":[{"id":"A16","pred":"fma_id","subj":"T16","obj":"http://purl.org/sig/ont/fma/fma45661"},{"id":"A17","pred":"fma_id","subj":"T17","obj":"http://purl.org/sig/ont/fma/fma312401"}],"text":"Clinical specimens collected on admission included the upper respiratory tract secretions and sputum. These specimens tested positive on 12 January for the CoV family by using a conventional nested RT-PCR [9]. Genomic sequencing analysis included Sanger and next generation sequencing were performed by the Emerging Infectious Diseases Health Science Center, the Thai Red Cross Society and the Thai National Institute of Health, Department of Medical Sciences and the sequence shared via the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database (EPI_ISL_403962). The sequencing protocol and details are provided in the Supplementary Materials. The patient recovered after testing negative for SARS-CoV-2, and returned to China without signs and symptoms on 18 January 2020."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T10","span":{"begin":55,"end":78},"obj":"Body_part"},{"id":"T11","span":{"begin":61,"end":78},"obj":"Body_part"},{"id":"T12","span":{"begin":94,"end":100},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0001557"},{"id":"A11","pred":"uberon_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"},{"id":"A12","pred":"uberon_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/UBERON_0007311"}],"text":"Clinical specimens collected on admission included the upper respiratory tract secretions and sputum. These specimens tested positive on 12 January for the CoV family by using a conventional nested RT-PCR [9]. Genomic sequencing analysis included Sanger and next generation sequencing were performed by the Emerging Infectious Diseases Health Science Center, the Thai Red Cross Society and the Thai National Institute of Health, Department of Medical Sciences and the sequence shared via the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database (EPI_ISL_403962). The sequencing protocol and details are provided in the Supplementary Materials. The patient recovered after testing negative for SARS-CoV-2, and returned to China without signs and symptoms on 18 January 2020."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T21","span":{"begin":316,"end":326},"obj":"Disease"},{"id":"T22","span":{"begin":525,"end":534},"obj":"Disease"},{"id":"T23","span":{"begin":713,"end":721},"obj":"Disease"},{"id":"T24","span":{"begin":713,"end":717},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Clinical specimens collected on admission included the upper respiratory tract secretions and sputum. These specimens tested positive on 12 January for the CoV family by using a conventional nested RT-PCR [9]. Genomic sequencing analysis included Sanger and next generation sequencing were performed by the Emerging Infectious Diseases Health Science Center, the Thai Red Cross Society and the Thai National Institute of Health, Department of Medical Sciences and the sequence shared via the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database (EPI_ISL_403962). The sequencing protocol and details are provided in the Supplementary Materials. The patient recovered after testing negative for SARS-CoV-2, and returned to China without signs and symptoms on 18 January 2020."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T27","span":{"begin":118,"end":124},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T28","span":{"begin":176,"end":177},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T29","span":{"begin":692,"end":699},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T30","span":{"begin":777,"end":779},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"Clinical specimens collected on admission included the upper respiratory tract secretions and sputum. These specimens tested positive on 12 January for the CoV family by using a conventional nested RT-PCR [9]. Genomic sequencing analysis included Sanger and next generation sequencing were performed by the Emerging Infectious Diseases Health Science Center, the Thai Red Cross Society and the Thai National Institute of Health, Department of Medical Sciences and the sequence shared via the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database (EPI_ISL_403962). The sequencing protocol and details are provided in the Supplementary Materials. The patient recovered after testing negative for SARS-CoV-2, and returned to China without signs and symptoms on 18 January 2020."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3","span":{"begin":79,"end":89},"obj":"http://purl.obolibrary.org/obo/GO_0046903"}],"text":"Clinical specimens collected on admission included the upper respiratory tract secretions and sputum. These specimens tested positive on 12 January for the CoV family by using a conventional nested RT-PCR [9]. Genomic sequencing analysis included Sanger and next generation sequencing were performed by the Emerging Infectious Diseases Health Science Center, the Thai Red Cross Society and the Thai National Institute of Health, Department of Medical Sciences and the sequence shared via the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database (EPI_ISL_403962). The sequencing protocol and details are provided in the Supplementary Materials. The patient recovered after testing negative for SARS-CoV-2, and returned to China without signs and symptoms on 18 January 2020."}

{"project":"LitCovid-sentences","denotations":[{"id":"T32","span":{"begin":0,"end":101},"obj":"Sentence"},{"id":"T33","span":{"begin":102,"end":209},"obj":"Sentence"},{"id":"T34","span":{"begin":210,"end":582},"obj":"Sentence"},{"id":"T35","span":{"begin":583,"end":663},"obj":"Sentence"},{"id":"T36","span":{"begin":664,"end":793},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Clinical specimens collected on admission included the upper respiratory tract secretions and sputum. These specimens tested positive on 12 January for the CoV family by using a conventional nested RT-PCR [9]. Genomic sequencing analysis included Sanger and next generation sequencing were performed by the Emerging Infectious Diseases Health Science Center, the Thai Red Cross Society and the Thai National Institute of Health, Department of Medical Sciences and the sequence shared via the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database (EPI_ISL_403962). The sequencing protocol and details are provided in the Supplementary Materials. The patient recovered after testing negative for SARS-CoV-2, and returned to China without signs and symptoms on 18 January 2020."}